BridgeBio Pharma
Discovers and develops medicines for patients with genetic diseases.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 2015
- Employees
- 839
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: BBIO
- Subsidiaries
- Eidos Therapeutics, QED Therapeutics, Calcilytix Therapeutics, ML Bio Solutions, Adrenas Therapeutics, Navire Pharma